Clinical Trials Browser

Phase 1/2 × Withdrawn × Poly(ADP-ribose) Polymerase Inhibitors × Clear all

NCT02396433 2015-08-25

Combination of Carboplatin, Eribulin Mesylate, and E7449 in BRCA-Related Cancers

Phase 1/2 Withdrawn

Breast Neoplasms